abstract |
The invention belongs to the field of medicine and pharmaceutical chemistry, and particularly relates to a novel anti-tumor drug composition, especially a drug composition of bisbenzylisoquinoline alkaloids (such as, berbamine and tetrandrine) and anthracycline compounds (such as, Aclacinomycin A), and its use for treating tumors. |